SGLT-2 Inhibitors, An Issue of Heart Failure Clinics

In this issue, guest editors bring their considerable expertise to this important topic. INDICE: Glucose-Lowering and Metabolic Effects of SGLT2 InhibitorsRenoprotective Effects of SGLT2 InhibitorsSGLT2 Inhibitors in Type 2 Diabetes MellitusSGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: A Paradigm Shift Toward Dual Cardio-Renal ProtectionSGLT2 Inhibitors and Heart Failure with Preserved Ejection FractionSGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical BenefitsSodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease EventsSGLT2 Inhibitors and Peripheral Vascular Events: A Review of the LiteratureSodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver DiseaseSGLT2 Inhibitors and Safety in Older PatientsSodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk

• ISBN: 978-0-323-96046-5
• Editorial: Elsevier
• Encuadernacion: Cartoné
• Páginas: 240
• Fecha Publicación: 11/10/2022
• Nº Volúmenes: 1
• Idioma: Inglés